Date:
2024-07-24 - 2024-07-28
Event category:
austrade-corporate:content-page-type/events/trade-event-exhibition
Time:
10:00:00 - 18:00:00 CST
Location:
Taiwan
Industry:
Biotechnology

BIO Asia-Taiwan is one of the premier, annual biotechnology events in Asia. In 2023, more than 120,000 exhibition visitors from 56 countries and 800 exhibitors joined BIO Asia-Taiwan. The event is a highly effective platform for your company to explore business opportunities and connect with key industry players. Participation offers a wide range of activities, including exhibition, conference and business matching and networking events.

Austrade Taipei is now inviting key Australian biotech companies to join its bespoke program at BIO Asia-Taiwan from 24 to 28 July 2024 in Taipei, Taiwan.  The highlights of Austrade program consist of the following:

  1. Australia-Taiwan Biotech Collaboration Forum, 24 July
    This Forum is a platform to promote Australian biotech capabilities and competitive advantage to an audience of likeminded Taiwanese biotech companies interested in commercial partnerships. The Forum offers value-added experiences for Australian business such as speaking opportunities and a one-on-one business matching program.

    In 2023, the Forum attracted 130 executives from 80 major biotech organizations followed on-site by over 120 one-on-one business matching meetings.

  2. Exhibition at Australia Pavilion at BIO Asia-Taiwan, 25-28 July
    Share collective space to display your industry capabilities at the Australia Pavilion and to connect with new contacts and engage with existing contacts.

    In 2023, the Australia Pavilion at BIO Asia-Taiwan was one of the largest and busiest platforms for Australian companies to showcase Australian clinical trials and biotech capabilities.

 

Date:
2024-07-24 - 2024-07-28
Time:
10:00:00 - 18:00:00 CST
Cost:
A$2,600
Venue details:
TaiNEX 1 & 2 halls, Nangang Exhibition Center, Taipei
Who should attend:

The program suits companies with innovative and competitive capabilities operating in (but not limited to):

  • Clinical trials and CRO companies
  • CDMO
  • Advanced therapeutics
  • Precision medicine
  • Medical research organisations
For more information contact:

Duli Chang
Senior Business Development Manager
E: duli.chang@austrade.gov.au

Sam Huang
Business Development Manager
E: sam.huang@austrade.gov.au

Register by:
Apply before 15 April 2024.